FluSNIFF Toddler
FluSNIFF-Toddler is a national study assessing the safety of the nasal flu vaccine in children under 2, delivered through NHS primary care.
.png)
Summary
Discover how the FluSNIFF trial ran from identification to follow-up without adding burden to busy GP teams, and what the model could mean for the paediatric trials you’re planning next. 1,913 children under-2 were randomised across the UK in just seven weeks. Families attended two short GP appointments with no blood tests, and completed a final follow-up by online questionnaire.
Share your details to access the case study
